-
1دورية أكاديمية
المؤلفون: Ma Q; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Yingxin Street #100, Xicheng District, Beijing, 100052, China., Zhang X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Yingxin Street #100, Xicheng District, Beijing, 100052, China., Yang J; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Yingxin Street #100, Xicheng District, Beijing, 100052, China., Li H; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Yingxin Street #100, Xicheng District, Beijing, 100052, China., Hao Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Yingxin Street #100, Xicheng District, Beijing, 100052, China. haoyz@ivdc.chinacdc.cn., Feng X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Yingxin Street #100, Xicheng District, Beijing, 100052, China. fengxia8@ivdc.chinacdc.cn.
المصدر: Scientific reports [Sci Rep] 2024 Aug 27; Vol. 14 (1), pp. 19845. Date of Electronic Publication: 2024 Aug 27.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
مواضيع طبية MeSH: 5' Untranslated Regions* , mRNA Vaccines* , Genes, Reporter*, Humans ; RNA, Messenger/genetics ; beta-Globins/genetics ; Animals ; HEK293 Cells
-
2دورية أكاديمية
المؤلفون: Parvin N; School of Mechanical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea., Joo SW; School of Mechanical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea., Mandal TK; School of Mechanical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.
المصدر: Biomolecules [Biomolecules] 2024 Aug 20; Vol. 14 (8). Date of Electronic Publication: 2024 Aug 20.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE
مواضيع طبية MeSH: Nanoparticles*/chemistry , mRNA Vaccines*, Humans ; RNA, Messenger/genetics ; Animals ; Vaccine Efficacy ; Vaccine Development ; Liposomes
-
3دورية أكاديمية
المؤلفون: Hu X; Department of Pediatrics, Weill Cornell Medicine, New York, New York., Karthigeyan KP; Department of Pediatrics, Weill Cornell Medicine, New York, New York., Herbek S; Department of Pediatrics, Weill Cornell Medicine, New York, New York., Valencia SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina., Jenks JA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina., Webster H; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina., Miller IG; Department of Pediatrics, Weill Cornell Medicine, New York, New York., Connors M; Department of Pediatrics, Weill Cornell Medicine, New York, New York., Pollara J; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina., Andy C; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York., Gerber LM; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York., Walter EB; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina., Edwards KM; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Bernstein DI; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Hou J; Moderna, Inc, Cambridge, Massachusetts., Koch M; Moderna, Inc, Cambridge, Massachusetts., Panther L; Moderna, Inc, Cambridge, Massachusetts., Carfi A; Moderna, Inc, Cambridge, Massachusetts., Wu K; Moderna, Inc, Cambridge, Massachusetts., Permar SR; Department of Pediatrics, Weill Cornell Medicine, New York, New York.
المصدر: The Journal of infectious diseases [J Infect Dis] 2024 Aug 16; Vol. 230 (2), pp. 455-466.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Adjuvants, Immunologic*/administration & dosage , Cytomegalovirus*/immunology , Cytomegalovirus*/genetics , Cytomegalovirus Infections*/prevention & control , Cytomegalovirus Infections*/immunology , Cytomegalovirus Infections*/virology , Cytomegalovirus Vaccines*/administration & dosage , Cytomegalovirus Vaccines*/immunology , mRNA Vaccines*/administration & dosage , mRNA Vaccines*/immunology , Polysorbates*/administration & dosage , Squalene*/administration & dosage , Squalene*/immunology, Humans ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antibody-Dependent Cell Cytotoxicity ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; RNA, Messenger/genetics ; RNA, Messenger/immunology ; Viral Envelope Proteins/immunology ; Viral Envelope Proteins/genetics
-
4دورية أكاديمية
المؤلفون: Iqbal SM; Moderna, Inc., Cambridge, MA, United States., Rosen AM; Moderna, Inc., Cambridge, MA, United States., Edwards D; Moderna, Inc., Cambridge, MA, United States., Bolio A; London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom., Larson HJ; London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States., Servin M; Moderna, Inc., Cambridge, MA, United States., Rudowitz M; Moderna, Inc., Cambridge, MA, United States., Carfi A; Moderna, Inc., Cambridge, MA, United States., Ceddia F; Moderna, Inc., Cambridge, MA, United States.
المصدر: Frontiers in public health [Front Public Health] 2024 Aug 08; Vol. 12, pp. 1429265. Date of Electronic Publication: 2024 Aug 08 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19 Vaccines* , COVID-19*/prevention & control , SARS-CoV-2* , mRNA Vaccines*, Humans ; RNA, Messenger ; Vaccines, Synthetic
-
5دورية أكاديمية
المؤلفون: Chen B; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Yang Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Wang X; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Yang W; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230022, P.R. China., Lu Y; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230022, P.R. China., Wang D; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Zhuo E; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Tang Y; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Su J; Department of Rehabilitation, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Tang G; Department of Orthopedics, Lu'an Hospital of Anhui Medical University, Lu'an, Anhui 237008, P.R. China., Shao S; Department of Orthopedics, Lu'an Hospital of Anhui Medical University, Lu'an, Anhui 237008, P.R. China., Gu K; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.
المصدر: International journal of oncology [Int J Oncol] 2024 Aug; Vol. 65 (2). Date of Electronic Publication: 2024 Jul 12.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasms*/immunology , Neoplasms*/therapy , Cancer Vaccines*/therapeutic use , Cancer Vaccines*/immunology , mRNA Vaccines* , Vaccine Development*, Humans ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/therapeutic use ; COVID-19/prevention & control ; COVID-19/immunology ; RNA, Messenger/genetics ; RNA, Messenger/immunology ; Precision Medicine/methods ; Immunotherapy/methods
-
6دورية أكاديمية
المؤلفون: Fazel F; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Doost JS; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Raj S; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Boodhoo N; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Karimi K; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Sharif S; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada. Electronic address: shayan@uoguelph.ca.
المصدر: Veterinary immunology and immunopathology [Vet Immunol Immunopathol] 2024 Aug; Vol. 274, pp. 110803. Date of Electronic Publication: 2024 Jul 04.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Scientific Country of Publication: Netherlands NLM ID: 8002006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2534 (Electronic) Linking ISSN: 01652427 NLM ISO Abbreviation: Vet Immunol Immunopathol Subsets: MEDLINE
مواضيع طبية MeSH: mRNA Vaccines*, Animals ; Vaccines, Synthetic/immunology ; Viral Vaccines/immunology ; Vaccination/veterinary ; RNA, Messenger/genetics
-
7دورية أكاديمية
المؤلفون: Hao T; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Li Y; Clinicopathological Diagnosis & Research Center, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People's Republic of China.; Key Laboratory of Tumor Molecular Pathology of Guangxi Higher Education Institutes, Baise, People's Republic of China., Liu P; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Wang X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Xu K; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Lei W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Li Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China., Zhang R; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi University, Nanning, People's Republic of China., Li X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Zhao X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China., Xu K; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China., Lu X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Bi Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Song H; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing People's Republic of China.; Beijing Institute of Infectious Diseases, Beijing, People's Republic of China., Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Zhu B; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.; Department of Pathogenic Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, People's Republic of China., Gao GF; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China.
المصدر: PLoS pathogens [PLoS Pathog] 2024 Sep 20; Vol. 20 (9), pp. e1012508. Date of Electronic Publication: 2024 Sep 20 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
مواضيع طبية MeSH: SARS-CoV-2*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , mRNA Vaccines*/immunology , Spike Glycoprotein, Coronavirus*/immunology , Spike Glycoprotein, Coronavirus*/genetics , Hemagglutinin Glycoproteins, Influenza Virus*/immunology , Hemagglutinin Glycoproteins, Influenza Virus*/genetics , COVID-19 Vaccines*/immunology, Animals ; Mice ; Humans ; Influenza Vaccines/immunology ; Antibodies, Viral/immunology ; Mice, Inbred BALB C ; Female ; Influenza A Virus, H1N1 Subtype/immunology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/immunology ; Vaccines, Synthetic/immunology ; Influenza, Human/prevention & control ; Influenza, Human/immunology ; Antibodies, Neutralizing/immunology
SCR Organism: SARS-CoV-2 variants
-
8دورية أكاديمية
المؤلفون: Chandra S; School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.; Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia., Wilson JC; School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.; Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia., Good D; School of Allied Health, Australian Catholic University, Brisbane, QLD-4014, Australia., Wei MQ; School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.; Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia.
المصدر: Oncology research [Oncol Res] 2024 Sep 18; Vol. 32 (10), pp. 1543-1564. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE
مواضيع طبية MeSH: mRNA Vaccines* , Cancer Vaccines*/immunology , Cancer Vaccines*/therapeutic use , Neoplasms*/immunology , Neoplasms*/therapy , Neoplasms*/prevention & control , Vaccine Development*, Humans ; COVID-19 Vaccines/immunology ; COVID-19/prevention & control ; COVID-19/immunology ; Vaccines, Synthetic/immunology ; RNA, Messenger/genetics ; Antigens, Neoplasm/immunology ; Antigens, Neoplasm/genetics ; SARS-CoV-2/immunology ; SARS-CoV-2/genetics
-
9دورية أكاديمية
المؤلفون: Wang Q; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; Pandemic Research Alliance Unit at the Wu Family Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Mellis IA; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Guo Y; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Gherasim C; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Valdez R; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Gordon A; Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: gordonal@umich.edu., Ho DD; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; Pandemic Research Alliance Unit at the Wu Family Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; Department of Microbiology and Immunology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA. Electronic address: dh2994@cumc.columbia.edu., Liu L; State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China; Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China. Electronic address: llh3411@whu.edu.cn.
المصدر: Cell reports. Medicine [Cell Rep Med] 2024 Sep 17; Vol. 5 (9), pp. 101701. Date of Electronic Publication: 2024 Aug 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Neutralizing*/immunology , Antibodies, Neutralizing*/blood , SARS-CoV-2*/immunology , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , COVID-19*/prevention & control , COVID-19*/immunology , COVID-19*/virology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Immunization, Secondary* , mRNA Vaccines*/immunology, Humans ; Female ; Adult ; Male ; Middle Aged ; Neutralization Tests ; Spike Glycoprotein, Coronavirus/immunology
SCR Organism: SARS-CoV-2 variants
-
10دورية أكاديمية
المؤلفون: Pather S; BioNTech SE, Mainz, Germany., Charpentier N; BioNTech SE, Mainz, Germany., van den Ouweland F; BioNTech SE, Mainz, Germany., Rizzi R; BioNTech SE, Mainz, Germany., Finlayson A; BioNTech SE, Mainz, Germany., Salisch N; BioNTech SE, Mainz, Germany., Muik A; BioNTech SE, Mainz, Germany., Lindemann C; BioNTech SE, Mainz, Germany., Khanim R; BioNTech SE, Mainz, Germany., Abduljawad S; BioNTech SE, Mainz, Germany., Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.
المصدر: Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126165. Date of Electronic Publication: 2024 Aug 27.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , COVID-19*/prevention & control , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , mRNA Vaccines*, Humans ; Risk Assessment ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/immunology ; Immunogenicity, Vaccine
SCR Organism: SARS-CoV-2 variants